Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer's disease.

Authors:
Sanz JM; Falzoni S; Rizzo R; Cipollone F; Zuliani G and 1 more

Journal:
Exp Gerontol

Publication Year: 2014

DOI:
10.1016/j.exger.2014.10.009

PMCID:
PMC4266448

PMID:
25456845

Journal Information

Full Title: Exp Gerontol

Abbreviation: Exp Gerontol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Geriatrics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest JSM, SF, RR, FC, GZ declare no conflict of interest. FDV has served as consultant for Biosceptre Ltd, a company involved in the development of P2X7R-targeted drugs."

Evidence found in paper:

"FDV is supported by grants from the Italian Association for Cancer Research (n. IG 5354), Telethon of Italy (n. GGP11014), ERA-NET Neuron Joint Transnational Project “Nanostroke”, the Ministry of Health of Italy (n. RF-2011-02348435), the Italian Ministry of Education, University and Research (n. RBAP11FXBC_001) and institutional funds from the University of Ferrara (FAR 2012)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025